Regeneron Pharmaceuticals: Time To Change My Strategy After Encouraging Q4 2024

Nemes Laszlo/iStock via Getty Images Regeneron Pharmaceuticals (NASDAQ:REGN) has been one of my favorite growth stocks over the past several years. In fact, REGN is one of my "Top Ideas" in the Compounding Healthcare investing group on Seeking Alpha. Yet, I have never published a premium article covering Regeneron for Seeking Alpha despite all of their R&D and financial achievements. Now, years later, I am deciding to post on Regeneron not because I am overly bullish on the ticker, but because I have been d ...